Macquarie Group’s Incannex Healthcare IXHL Stock Holding History

Macquarie Group’s Portfolio IXHL Stock Details IXHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-20	Closed	-$1.76K	–	1791
2024 Q2	$1.76K	Hold	20	–	–	﹤0.01%	1811
2024 Q1	$2	Buy	+20	New	+$2.4K	﹤0.01%	1851

Other funds holding IXHL

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Macquarie Group's IXHL Position: Q3 2024 in Review

Macquarie Group sold out of Incannex Healthcare (IXHL) in Q3 2024, closing a stake of 20 shares — an estimated $1.76K sold.

Macquarie Group first reported a position in IXHL in Q1 2024 and held it in 2 quarters. The position peaked at $1.76K in Q2 2024. 11 funds tracked by Wall St. Rank hold IXHL as of Q3 2024.

Macquarie Group reported no remaining Incannex Healthcare position as of Q3 2024 after selling out during the quarter.
Macquarie Group sold 20 Incannex Healthcare shares in Q3 2024, an estimated $1.76K.
Macquarie Group first reported a position in Incannex Healthcare in Q1 2024 and held it in 2 quarters.
Macquarie Group's Incannex Healthcare position peaked at $1.76K in Q2 2024.
11 funds tracked by Wall St. Rank held Incannex Healthcare as of Q3 2024.

Based on Macquarie Group's 13F filing for Q3 2024, filed 14 Nov 2024.